Coherus Oncology Appoints Arvind Sood as Chief Strategy and Corporate Affairs Officer

jueves, 6 de noviembre de 2025, 1:56 pm ET1 min de lectura
CHRS--

Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer, overseeing corporate development, investor relations, and government affairs. Sood brings over 20 years of experience from Amgen and other biotechnology companies. He will play a key role in promoting the company's value proposition and exploring business development opportunities for its promising cancer therapies.

Coherus Oncology Appoints Arvind Sood as Chief Strategy and Corporate Affairs Officer

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios